|
|
||||||||
1 Department of Biotechnology, Faculty of Life Science and Biotechnology, Fukuyama University, 985 Sanzo, Higashimura-cho, Fukuyama-shi, Hiroshima 729-0292, Japan
2 Central Research Laboratories, Hokko Chemical Industry Co., Ltd, 2165 Toda, Atsugi-shi, Kanagawa 243-0023, Japan
3 Department of Environment and Information Science, Faculty of Human Culture and Sciences, Fukuyama University, 985 Sanzo, Higashimura-cho, Fukuyama-shi, Hiroshima 729-0292, Japan
Correspondence
Ken-ichi Yoshida
kyoshida{at}bt.fubt.fukuyama-u.ac.jp
The myo-inositol catabolism pathway of Bacillus subtilis has not been fully characterized but was proposed to involve step-wise multiple reactions that finally yielded acetyl-CoA and dihydroxyacetone phosphate. It is known that the iolABCDEFGHIJ operon is responsible for the catabolism of inositol. IolG catalyses the first step of myo-inositol catabolism, the dehydrogenation of myo-inositol, producing 2-keto-myo-inositol (inosose). The second step was thought to be the dehydration of inosose. Genetic and biochemical analyses of the iol genes led to the identification of iolE, encoding the enzyme for the second step of inositol catabolism, inosose dehydratase. The reaction product of inosose dehydratase was identified as D-2,3-diketo-4-deoxy-epi-inositol.
This article has been cited by other articles:
![]() |
K.-i. Yoshida, M. Yamaguchi, T. Morinaga, M. Kinehara, M. Ikeuchi, H. Ashida, and Y. Fujita myo-Inositol Catabolism in Bacillus subtilis J. Biol. Chem., April 18, 2008; 283(16): 10415 - 10424. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Krings, K. Krumbach, B. Bathe, R. Kelle, V. F. Wendisch, H. Sahm, and L. Eggeling Characterization of myo-Inositol Utilization by Corynebacterium glutamicum: the Stimulon, Identification of Transporters, and Influence on L-Lysine Formation J. Bacteriol., December 1, 2006; 188(23): 8054 - 8061. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-i. Yoshida, M. Yamaguchi, T. Morinaga, M. Ikeuchi, M. Kinehara, and H. Ashida Genetic Modification of Bacillus subtilis for Production of D-chiro-Inositol, an Investigational Drug Candidate for Treatment of Type 2 Diabetes and Polycystic Ovary Syndrome Appl. Envir. Microbiol., February 1, 2006; 72(2): 1310 - 1315. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |